GlassScriptPhysician profile
Susan A Moison
NPI 1225026107
$820.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $250 · 2021: $343 · 2022: $25.67 · 2023: $48.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.91 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2020 | |
| Pfizer INC. | $96.12 | 2019-2021 | |
| Hologic Sales and Service, LLC | $70.29 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Roche Diagnostics Corporation | $62.70 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.13 | 2019-2020 | |
| Exeltis, USA INC. | $38.11 | 2021 | |
| Merck Sharp & Dohme LLC | $34.87 | 2019-2020 | |
| Therapeuticsmd, INC. | $29.04 | 2019 | |
| Organon LLC | $25.67 | 2022 | |
| Mission Pharmacal Company | $23.56 | 2021 | |
| Organogenesis INC. | $21.47 | 2021 | |
| Ascend Therapeutics US, LLC | $15.47 | 2021 | |
| Avion Pharmaceuticals | $15.41 | 2019 | |
| Coopersurgical, INC. | $12.99 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Moison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.